Pulsenmore Ltd. (TLV:PULS)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,960.00
+43.00 (2.24%)
At close: Jan 9, 2026
Pulsenmore Market Cap
Pulsenmore has a market cap or net worth of 127.43 million as of January 9, 2026. Its market cap has decreased by -56.22% in one year.
Market Cap
127.43M
Enterprise Value
42.50M
Revenue
9.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,960.00
Market Cap Chart
Since June 15, 2021, Pulsenmore's market cap has decreased from 795.01M to 127.43M, a decrease of -83.97%. That is a compound annual growth rate of -32.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 127.43M | -6.18% |
| Dec 31, 2025 | 135.82M | -46.02% |
| Dec 31, 2024 | 251.62M | -29.08% |
| Dec 31, 2023 | 354.81M | -4.28% |
| Dec 29, 2022 | 370.68M | -42.16% |
| Dec 30, 2021 | 640.93M | -19.38% |
| Jun 15, 2021 | 795.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 115.77B |
| Danel (Adir Yeoshua) | 2.91B |
| Kamada | 1.49B |
| BrainsWay | 1.46B |
| SofWave Medical | 1.18B |
| Bait Bakfar | 1.06B |
| Ilex Medical | 774.22M |
| Novolog (Pharm-Up 1966) | 664.14M |